Regent Pacific Group Ltd (fra:RPG) Share Price

Company Profile

Business description
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
Contact
5 Queen's Road Central
8th Floor, Henley Building
Hong Kong
HKG
T: +852 25146111
https://www.endurancerp.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
16

Recommended

China’s slowing economy could weigh on BHP’s future growth.

Tyger Fitzpatrick | 16 July 2026

Here’s three high-quality growth companies with wide moats.

Tyger Fitzpatrick | 16 July 2026

While markets chase AI hype, this data centre company offers real data center earnings and a visible growth pipeline.

Brian Han | 14 July 2026

Index	Last price	Change	% Change
All Ordinaries	9,036.90	13.00	-0.14%
CAC 40	8,377.86	4.57	-0.05%
DAX 40	24,915.49	84.04	-0.34%
Dow JONES (US)	52,429.67	228.97	-0.43%
FTSE 100	10,572.24	56.32	0.54%
HKSE	25,008.60	327.50	1.33%
NASDAQ	25,876.00	393.23	-1.50%
Nikkei 225	66,835.54	1,915.97	-2.79%
NZX 50 Index	13,614.78	20.29	-0.15%
S&P 500	7,521.66	50.74	-0.67%
S&P/ASX 200	8,840.70	15.50	-0.18%
SSE Composite Index	3,882.41	73.17	-1.85%